Skip to main content

West Virginia To Get $26M Opioid Settlement From Endo

West Virginia To Get $26M Opioid Settlement From Endo

West Virginia To Get $26M Opioid Settlement From Endo

Introduction

Endo Health Solutions will pay $26 million as a settlement to West Virginia for the company's role in fueling the opioid crisis in the state, which created havoc among the communities.

The company announced the settlement just before the trial that took place on Monday, where the state has sued three opioid manufacturers Allergan, Janssen Pharmaceuticals Inc., and Teva Pharmaceuticals Inc. Attorney General Patrick Morrisey informed that even Endo would have been part of the trial if the company would have failed to reach a settlement over the last several months with the state. In 2019, West Virginia sued all four drug companies and their subsidiaries.

As per the settlement, the money would be used to develop programmes that would help to fight the opioid addiction problems in the state. It even mandates Endo not to make false or deceptive statements about opioids and stop the promotion of opioids for treating pain.

In a similar lawsuit in 2019, Boone County Circuit Court accused Endo of mischaracterizing and failing to disclose the severe risk of opioid addiction by overstating the benefits of opioid therapy and promoting higher dosage of opioids by withholding the risks. The state alleged that Endo rebranded the drug with a new name Opana with a new colour.

West Virginia alleges that the manufacturers used a deceiving strategy to sell the drugs by persuading doctors to prescribe opioids for minor pain conditions. The attorney general’s office notified that the trial could take up to two months.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!